Could a vaccine made from your own tumor fight advanced cancer?
NCT ID NCT05807035
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial is testing a personalized vaccine made from a patient's own tumor tissue. The goal is to see if it is safe and can help the immune system recognize and attack advanced solid cancers. About 30 adults with advanced solid tumors who have already tried other treatments will receive the vaccine, either alone or with standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
autologous tumor vaccine (Radvax) with polysaccharide adjuvant
What this could lead to
If it works, this could point toward a personalized treatment that helps control advanced solid cancers by training the immune system to attack the tumor.
What could go wrong
This is a very early Phase 1 trial with only 30 people, so it is primarily testing safety, not effectiveness. The vaccine may not shrink tumors or improve survival, and there is a risk of side effects like immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARASMI
RECRUITINGAdelaide, South Australia, 5046, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••